Form D · Biotechnology
CURIS INC
Lexington, MA · CIK 0001108205
Offering snapshot reported May 4, 2012 · SEC filing
- Reported sold
- $964K Offering amount: $964K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 30, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 4, 2012 | Initial | $964,000 | No comparison | 2 | SEC filing |
| Aug 13, 2007 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-177721
The securities were issued as partial consideration for certain rights and licenses granted to the Issuer pursuant to the terms of license agreements that were entered into by the Issuer with two universities.
Source: Form D, filed May 4, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Susan B. Bayh | Director |
| Michael P. Gray | Executive |
| Martyn D. Greenacre | Director |
| Kenneth I. Kaitin | Director |
| Robert E. Martell | Director |
| James R. Mc Nab, Jr. | Director |
| Mark W. Noel | Executive |
| Daniel R. Passeri | Director, Executive |
| Marc Rubin | Director |
| James R. Tobin | Director |
| Maurizio Voi | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4 Maguire Road
Lexington, MA, 02421
Lexington, MA, 02421